Facebook
X
LinkedIn
ForwardRadiopharmaceutical Program Justification and Initial Start-up
This session addresses the initial steps required for building a radiopharmaceutical program. Crucial to starting a program is understanding the business case, which includes understanding the potential referral stream, reimbursement, personnel, space, and equipment costs to start a program. The speakers review space, radioactive materials license, and protocol requirements for starting a program. Finally, we learn about the clinic and staffing needs to start a program. We seek to educate using experienced professionals from freestanding centers, hospitals, and consulting organizations.
Target Audience
This meeting was designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists, radiation therapists, radiation dosimetrists, specialists, nuclear physicians and practice administrators.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand the business case for starting a radiopharmaceutical therapy program.
- Know the basic space and regulatory requirements for radiopharmaceutical therapy.
- Appreciate the personnel and clinical process needs to deliver a radiopharmaceutical program.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.